233 related articles for article (PubMed ID: 36873419)
1. Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis.
Yamashita Y; Umemura T; Kimura T; Joshita S; Hirohara J; Nakano T; Komori A; Tanaka A
JHEP Rep; 2023 Apr; 5(4):100662. PubMed ID: 36873419
[TBL] [Abstract][Full Text] [Related]
2. The Albumin-Bilirubin Score as a Predictor of Liver-Related Mortality in Primary Biliary Cholangitis with Compensated Cirrhosis.
Chen Q; Zhong R; Wang Y; Kui Y; Wen X; Huang J; Jin Q
Dig Dis; 2023; 41(6):946-956. PubMed ID: 37321186
[TBL] [Abstract][Full Text] [Related]
3. Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis.
Tanaka A; Hirohara J; Nakano T; Matsumoto K; Chazouillères O; Takikawa H; Hansen BE; Carrat F; Corpechot C
J Hepatol; 2021 Sep; 75(3):565-571. PubMed ID: 33882268
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Transplant-Free Survival through Albumin-Bilirubin Score in Primary Biliary Cholangitis.
Fujita K; Nomura T; Morishita A; Shi T; Oura K; Tani J; Kobara H; Tsutsui K; Himoto T; Masaki T
J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31430975
[TBL] [Abstract][Full Text] [Related]
5. Determinants of the effectiveness of bezafibrate combined with ursodeoxycholic acid in patients with primary biliary cholangitis.
Matsumoto K; Hirohara J; Takeuchi A; Miura R; Asaoka Y; Nakano T; Tanaka A
Hepatol Res; 2023 Oct; 53(10):989-997. PubMed ID: 37291072
[TBL] [Abstract][Full Text] [Related]
6. The albumin-bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC.
Ito T; Ishigami M; Morooka H; Yamamoto K; Imai N; Ishizu Y; Honda T; Nishimura D; Tada T; Yasuda S; Toyoda H; Kumada T; Fujishiro M
Sci Rep; 2020 Oct; 10(1):17812. PubMed ID: 33082429
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.
Harms MH; van Buuren HR; Corpechot C; Thorburn D; Janssen HLA; Lindor KD; Hirschfield GM; Parés A; Floreani A; Mayo MJ; Invernizzi P; Battezzati PM; Nevens F; Ponsioen CY; Mason AL; Kowdley KV; Lammers WJ; Hansen BE; van der Meer AJ
J Hepatol; 2019 Aug; 71(2):357-365. PubMed ID: 30980847
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of Mac-2-binding protein glycosylation isomer as a biomarker for albumin-bilirubin grade and the Controlling Nutritional Status score in chronic liver disease: investigation of cut-off values by the type of chronic liver disease.
Ishikawa T; Kodama E; Kobayashi T; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T
Ann Palliat Med; 2022 Aug; 11(8):2658-2667. PubMed ID: 35815452
[TBL] [Abstract][Full Text] [Related]
9. Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis.
Overi D; Carpino G; Cristoferi L; Onori P; Kennedy L; Francis H; Zucchini N; Rigamonti C; Viganò M; Floreani A; D'Amato D; Gerussi A; Venere R; Alpini G; Glaser S; Alvaro D; Invernizzi P; Gaudio E; Cardinale V; Carbone M
JHEP Rep; 2022 Nov; 4(11):100556. PubMed ID: 36267871
[TBL] [Abstract][Full Text] [Related]
10. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score.
Chan AW; Chan RC; Wong GL; Wong VW; Choi PC; Chan HL; To KF
J Gastroenterol Hepatol; 2015 Sep; 30(9):1391-6. PubMed ID: 25753927
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Scores for Ursodeoxycholic Acid-Treated Patients Predict Graft Loss and Mortality in Recurrent Primary Biliary Cholangitis after Liver Transplantation.
Montano-Loza AJ; Lytvyak E; Hirschfield G; Hansen BE; Ebadi M; Berney T; Toso C; Magini G; Villamil A; Nevens F; Van den Ende N; Pares A; Ruiz P; Terrabuio D; Trivedi PJ; Abbas N; Donato MF; Yu L; Landis C; Dumortier J; Dyson JK; van der Meer AJ; de Veer R; Pedersen M; Mayo M; Manns MP; Taubert R; Theresa K; Belli LS; Mazzarelli C; Stirnimann G; Floreani A; Cazzagon N; Russo FP; Burra P; Zigmound U; Houri I; Carbone M; Mulinacci G; Fagiuoli S; Pratt DS; Bonder A; Schiano TD; Haydel B; Lohse A; Schramm C; Rüther D; Casu S; Verhelst X; Beretta-Piccoli BT; Robles M; Mason AL; Corpechot C;
J Hepatol; 2024 May; ():. PubMed ID: 38821360
[TBL] [Abstract][Full Text] [Related]
12. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of Autoimmune Liver Disease and Real-World Treatment Experience from a Tertiary Care Hospital.
Taneja S; Mehtani R; De A; Mitra S; Rathi S; Verma N; Premkumar M; Minz R; Duseja A; Das A; Singh V; Dhiman RK; Chawla YK
J Clin Exp Hepatol; 2023; 13(2):241-251. PubMed ID: 36950480
[TBL] [Abstract][Full Text] [Related]
14. Prognostic scores in primary biliary cholangitis patients with advanced disease.
Feng J; Xu JM; Fu HY; Xie N; Bao WM; Tang YM
World J Gastrointest Surg; 2023 Aug; 15(8):1774-1783. PubMed ID: 37701680
[TBL] [Abstract][Full Text] [Related]
15. Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis.
Honda A; Tanaka A; Kaneko T; Komori A; Abe M; Inao M; Namisaki T; Hashimoto N; Kawata K; Takahashi A; Ninomiya M; Kang JH; Arakawa M; Yamagiwa S; Joshita S; Umemura T; Sato K; Kaneko A; Kikuchi K; Itakura J; Nomura T; Kakisaka K; Fujii H; Kawada N; Takikawa Y; Masaki T; Ohira H; Mochida S; Yoshiji H; Iimuro S; Matsuzaki Y; Takikawa H;
Hepatology; 2019 Dec; 70(6):2035-2046. PubMed ID: 30737815
[TBL] [Abstract][Full Text] [Related]
16. Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.
Corpechot C; Chazouillères O; Belnou P; Montano-Loza AJ; Mason A; Ebadi M; Eurich D; Chopra S; Jacob D; Schramm C; Sterneck M; Bruns T; Reuken P; Rauchfuss F; Roccarina D; Thorburn D; Gerussi A; Trivedi P; Hirschfield G; McDowell P; Nevens F; Boillot O; Bosch A; Giostra E; Conti F; Poupon R; Parés A; Reig A; Donato MF; Malinverno F; Floreani A; Russo FP; Cazzagon N; Verhelst X; Goet J; Harms M; van Buuren H; Hansen B; Carrat F; Dumortier J;
J Hepatol; 2020 Sep; 73(3):559-565. PubMed ID: 32275981
[TBL] [Abstract][Full Text] [Related]
17. Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC.
Zhao S; Wang M; Yang Z; Tan K; Zheng D; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):539. PubMed ID: 32411762
[TBL] [Abstract][Full Text] [Related]
18. Combined albumin-bilirubin grade and Mac-2 binding protein glycosylation isomer as a useful predictor in compensated liver cirrhosis.
Nishikawa H; Enomoto H; Yoh K; Iwata Y; Sakai Y; Kishino K; Ikeda N; Takashima T; Aizawa N; Takata R; Hasegawa K; Ishii N; Yuri Y; Nishimura T; Iijima H; Nishiguchi S
Medicine (Baltimore); 2019 Dec; 98(50):e18366. PubMed ID: 31852142
[TBL] [Abstract][Full Text] [Related]
19. PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales.
Colapietro F; Gershwin ME; Lleo A
J Transl Autoimmun; 2023; 6():100188. PubMed ID: 36684809
[TBL] [Abstract][Full Text] [Related]
20. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase.
Murillo Perez CF; Harms MH; Lindor KD; van Buuren HR; Hirschfield GM; Corpechot C; van der Meer AJ; Feld JJ; Gulamhusein A; Lammers WJ; Ponsioen CY; Carbone M; Mason AL; Mayo MJ; Invernizzi P; Battezzati PM; Floreani A; Lleo A; Nevens F; Kowdley KV; Bruns T; Dalekos GN; Gatselis NK; Thorburn D; Trivedi PJ; Verhelst X; Parés A; Janssen HLA; Hansen BE;
Am J Gastroenterol; 2020 Jul; 115(7):1066-1074. PubMed ID: 32618657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
